Login / Signup

The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients.

Veli YazisizVural Taner Yilmazİsmail UÇarOzgur DandinBengisu AslanFunda ErbasanHüseyin KoçakMustafa Ender TerzioĞlu
Published in: Archives of rheumatology (2021)
Our results support that anti-IL-1 agents can be used effectively and safely in renal transplant patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • rheumatoid arthritis
  • prognostic factors
  • peritoneal dialysis